Anika Therapeutics Announces Full Market Release Of Integrity Implant System

Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika's proprietary hyaluronic acid (HA) regenerative portfolioOver 300 surgeries

BenzingaJul 11 20:36

Express News | Anika Therapeutics Inc - Integrity Implant System Is Now in Full Market Release and Broadly Available Across U.s

BreakingsJul 11 20:30

Anika Announces Full Market Release of the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs

Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika's proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the

GlobeNewswireJul 11 20:30

HealthpointCapital and The Orthopaedic Summit: Evolving Techniques Course (OSET) Announce Inaugural Investor Day at Fontainebleau Las Vegas

SAN DIEGO, June 11, 2024 /PRNewswire/ -- HealthpointCapital, the leading private equity firm exclusively focused on the Musculoskeletal Healthcare sector, in partnership with The Orthopaedic Summit:

PR NewswireJun 11 21:30

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3, 2024, Anika granted: (i)

GlobeNewswireJun 8 04:01

Stephens & Co. Reiterates Equal-Weight on Anika Therapeutics, Maintains $24 Price Target

Stephens & Co. analyst George Sellers reiterates Anika Therapeutics with a Equal-Weight and maintains $24 price target.

Analyst UpgradesMay 29 21:21